← Leaderboards
Daruka Mahadevan
University Of Rochester
$1,796,678
Attributed
$1,796,678
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $328.1K · FY2008–18$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,796,678 · 2
By mechanism
P50$1,402,029 · 1
P30$394,649 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Jonathan W Friedberg$9,248,735
- Jiyong Zhao$2,625,979
Others in their field
Top investigators on “Cancer Center”
- Leonard Freedman · Leidos Biomedical Research, Inc.$885,275,552
- David Heimbrook · Leidos Biomedical Research, Inc.$793,360,762
- Larry Arthur$473,862,081
- Richard A Gibbs · Baylor College Of Medicine$257,275,004
- Lynn Briscoe · Leidos Biomedical Research, Inc.$248,567,868
- Norman Wolmark · Nsabp Foundation, Inc.$237,419,252
Research focus
Cancer CenterArizonaDrug KineticsS LymphomaInnovationCancer Center Support GrantLaboratoriesFundingHigh RiskGrantBiological MarkersContractsCatchment AreaCancer ImagingCancer TherapyAnalytical ChemistryBaseClinical ResearchDevicesDetectionBioinformaticsGenomicsChemopreventionIndustry
Grant awards (12)
Early Phase Clinical Research Support$123,786
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$16,665
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$13,888
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$11,110
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$6,221
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$102,724
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$120,255
P30 · FY2016 · CA · contact PI
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas$279,329
P50 · FY2012 · CA · contact PI
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas$269,398
P50 · FY2011 · CA · contact PI
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas$287,712
P50 · FY2010 · CA · contact PI
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas$328,078
P50 · FY2009 · CA · contact PI
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas$237,512
P50 · FY2008 · CA · contact PI